• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Sweden Pharmaceuticals and Healthcare Report Q4 2010 - Product Image

Sweden Pharmaceuticals and Healthcare Report Q4 2010

  • ID: 1372902
  • August 2010
  • Region: Sweden
  • 58 Pages
  • Business Monitor International

Business Monitor International's Sweden Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Sweden's pharmaceuticals and healthcare industry.

In BMI's Q410 Pharmaceuticals & Healthcare Business Environment Ratings, the Western Europe region scored a total of 64.5 out of a 100. The attractiveness of the region to pharmaceutical firms stems from the fact that its countries are key revenue sources for 'big pharma', particularly for companies selling high-end products, as per-capita spending is substantially higher than in emerging markets. However, it is BMI's view that drug companies will face many challenges in Western Europe over the next decade, including the need to reduce fiscal deficits, the patent cliff, added regulatory hurdles and increasingly scrupulous cost-effectiveness assessments of new drugs – all factors that will influence the risk and reward scores assigned to markets in the region.

BMI considers Sweden one of the most attractive markets globally and in Western READ MORE >

Note: Product cover images may vary from those shown

Executive Summary

SWOT Analysis
- Sweden Pharmaceuticals And Healthcare Industry SWOT
- Sweden Political SWOT
- Sweden Economic SWOT

Pharmaceutical Business Environment Ratings
- Table: Western Europe – Regional Pharmaceuticals Business Environment Ratings, Q410
- Rewards
- Risks
- Market Summary
- Regulatory Regime
- Pricing and Reimbursement
- Intellectual Property Regime

Industry Forecast Scenario
- Overall Market Forecast
- Healthcare Market Forecast
- Macroeconomic Forecast
- Table: Sweden – Economic Activity
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast

Medical Devices
- Epidemiology
- Clinical Trials Sector

Competitive Landscape
- Manufacturing Sector
- Distribution Sector

Company Profiles
- Meda
- Swedish Biovitrum

Country Snapshot: Sweden Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators, 2001-2006
- Table: Consumer Expenditure, 2000-2012 (US$)
- Table: Average Annual Wages, 2000-2012

BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceuticals Business Environment Ratings
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
- Forecast Tables

Note: Product cover images may vary from those shown

- Meda
- Swedish Biotrivim

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos